• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆红素抑制核因子-κB的激活:人胆红素还原酶对抑制作用的逆转。

Biliverdin inhibits activation of NF-kappaB: reversal of inhibition by human biliverdin reductase.

作者信息

Gibbs Peter E M, Maines Mahin D

机构信息

Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY 14642, USA.

出版信息

Int J Cancer. 2007 Dec 1;121(11):2567-74. doi: 10.1002/ijc.22978.

DOI:10.1002/ijc.22978
PMID:17683071
Abstract

hBVR functions in the cell as a reductase and as a kinase. In the first capacity, it reduces biliverdin, the product of HO activity, to the effective intracellular antioxidant, bilirubin; as a dual-specificity kinase (S/T/Y) it activates the MAPK and IGF/IRK receptor signal transduction pathways. NF-kappaB and the MAPK pathway are activated by ROS, which results in the activation of stress-inducible genes, including ho-1. Presently, we report on the negative effect of biliverdin on NF-kappaB activation and the converse effect of hBVR. Biliverdin, in a concentration- and time-dependent manner, inhibited transcriptional activity of NF-kappaB in HEK293A cells. Nuclear extracts from biliverdin-treated cells show reduced DNA binding of NF-kappaB in an electromobility shift assay, whereas extracts from cells treated with TNF-alpha showed enhanced binding. Coimmunoprecipitation data show hBVR binds to the 65 kDa subunit of NF-kappaB, and that this is dependent on activation by TNF-alpha. Overexpression of hBVR enhanced both the basal and TNF-alpha-mediated activation of NF-kappaB and also that of the NF-kappaB-activated iNOS gene. Also, overexpression of hBVR arrested the cell cycle in the G(1)/G(0) phase and reduced the number of cells in S phase. Similar results were observed with MCF-7 cells. Because of the Janus nature of NF-kappaB activity in the cell and the inhibitory action of biliverdin, the present findings provide a foundation for therapeutic intervention in inflammatory diseases and cancer that may be attained by preventing reduction of biliverdin. On the other hand, by increasing BVR levels beneficial functions of NF-kappaB might be augmented.

摘要

hBVR在细胞中作为还原酶和激酶发挥作用。作为还原酶,它将HO活性产物胆绿素还原为有效的细胞内抗氧化剂胆红素;作为双特异性激酶(S/T/Y),它激活MAPK和IGF/IRK受体信号转导途径。NF-κB和MAPK途径由ROS激活,这导致包括ho-1在内的应激诱导基因的激活。目前,我们报道了胆绿素对NF-κB激活的负面影响以及hBVR的相反作用。胆绿素以浓度和时间依赖性方式抑制HEK293A细胞中NF-κB的转录活性。在电泳迁移率变动分析中,胆绿素处理细胞的核提取物显示NF-κB的DNA结合减少,而用TNF-α处理的细胞提取物显示结合增强。免疫共沉淀数据显示hBVR与NF-κB的65 kDa亚基结合,并且这依赖于TNF-α的激活。hBVR的过表达增强了NF-κB的基础激活和TNF-α介导的激活以及NF-κB激活的iNOS基因的激活。此外,hBVR的过表达使细胞周期停滞在G(1)/G(0)期并减少S期细胞数量。在MCF-7细胞中也观察到了类似结果。由于细胞中NF-κB活性的两面性以及胆绿素的抑制作用,本研究结果为通过防止胆绿素还原来治疗炎症性疾病和癌症提供了治疗干预的基础。另一方面,通过增加BVR水平,NF-κB的有益功能可能会增强。

相似文献

1
Biliverdin inhibits activation of NF-kappaB: reversal of inhibition by human biliverdin reductase.胆红素抑制核因子-κB的激活:人胆红素还原酶对抑制作用的逆转。
Int J Cancer. 2007 Dec 1;121(11):2567-74. doi: 10.1002/ijc.22978.
2
Characterization of the human biliverdin reductase gene structure and regulatory elements: promoter activity is enhanced by hypoxia and suppressed by TNF-alpha-activated NF-kappaB.鉴定人胆红素还原酶基因结构和调控元件:低氧可增强其启动子活性,而 TNF-α 激活的 NF-κB 可抑制其活性。
FASEB J. 2010 Sep;24(9):3239-54. doi: 10.1096/fj.09-144592. Epub 2010 Apr 21.
3
Human biliverdin reductase suppresses Goodpasture antigen-binding protein (GPBP) kinase activity: the reductase regulates tumor necrosis factor-alpha-NF-kappaB-dependent GPBP expression.人胆红素还原酶抑制 Goodpasture 抗原结合蛋白 (GPBP) 激酶活性:还原酶调节肿瘤坏死因子-α-NF-κB 依赖性 GPBP 表达。
J Biol Chem. 2010 Apr 23;285(17):12551-8. doi: 10.1074/jbc.M109.032771. Epub 2010 Feb 22.
4
Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.人胆绿素还原酶与Akt/蛋白激酶B及磷脂酰肌醇依赖性激酶1的相互作用调节糖原合酶激酶3的活性:Akt激活的一种新机制。
FASEB J. 2016 Aug;30(8):2926-44. doi: 10.1096/fj.201600330RR. Epub 2016 May 10.
5
Formation of ternary complex of human biliverdin reductase-protein kinase Cδ-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-κB, and inducible nitric-oxidase synthase (iNOS).人胆红素还原酶-蛋白激酶 Cδ-ERK2 蛋白三元复合物的形成对于 ERK2 介导的 Elk1 蛋白、核因子-κB 和诱导型一氧化氮合酶(iNOS)的激活至关重要。
J Biol Chem. 2012 Jan 6;287(2):1066-79. doi: 10.1074/jbc.M111.279612. Epub 2011 Nov 7.
6
Regulation of TNF-alpha-activated PKC-zeta signaling by the human biliverdin reductase: identification of activating and inhibitory domains of the reductase.人胆绿素还原酶对肿瘤坏死因子-α激活的蛋白激酶C-ζ信号通路的调控:还原酶激活域和抑制域的鉴定
FASEB J. 2007 Dec;21(14):3949-62. doi: 10.1096/fj.07-8544com. Epub 2007 Jul 17.
7
Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.厚朴酚通过抑制 IKK 激活来抑制肿瘤坏死因子-α 刺激的核因子-κB 激活及核因子-κB 调控的基因表达。
Biochem Pharmacol. 2005 Nov 15;70(10):1443-57. doi: 10.1016/j.bcp.2005.08.011. Epub 2005 Sep 21.
8
Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin.胆绿素还原酶是一种将血红素转运至细胞核的转运蛋白,对于血晶素调节HO-1基因表达至关重要。
Biochem J. 2008 Aug 1;413(3):405-16. doi: 10.1042/BJ20080018.
9
Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells.小干扰RNA介导的人胆绿素还原酶基因沉默而非血红素加氧酶-1基因沉默,可减弱亚砷酸盐介导的加氧酶诱导,并增加293A肾细胞的凋亡。
J Biol Chem. 2005 Apr 29;280(17):17084-92. doi: 10.1074/jbc.M413121200. Epub 2005 Feb 28.
10
Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1.胆红素还原酶,一种诱导激活转录因子2和血红素加氧酶1的新型调节因子。
J Biol Chem. 2004 May 7;279(19):19916-23. doi: 10.1074/jbc.M314251200. Epub 2004 Feb 25.

引用本文的文献

1
Bilirubin metabolism in relation to cancer.胆红素代谢与癌症的关系。
Front Oncol. 2025 Apr 11;15:1570288. doi: 10.3389/fonc.2025.1570288. eCollection 2025.
2
An Alternative to Biliverdin, Mesobiliverdin IXα and Mesobiliverdin-Enriched Microalgae: A Review on the Production and Applications of Mesobiliverdin-Related Products.一种替代胆红素、中胆红素 IXα 和富含中胆红素的微藻的物质:关于中胆红素相关产品的生产与应用的综述
Molecules. 2025 Mar 19;30(6):1379. doi: 10.3390/molecules30061379.
3
Severity of Repetitive Mild Traumatic Brain Injury Depends on Microglial Heme Oxygenase-1 and Carbon Monoxide.
重复性轻度创伤性脑损伤的严重程度取决于小胶质细胞血红素加氧酶-1和一氧化碳。
Eur J Neurosci. 2025 Jan;61(2):e16666. doi: 10.1111/ejn.16666.
4
Role of Natural Compounds Modulating Heme Catabolic Pathway in Gut, Liver, Cardiovascular, and Brain Diseases.天然化合物对血红素代谢途径的调控作用在肠道、肝脏、心血管和脑部疾病中的作用。
Biomolecules. 2024 Jan 2;14(1):63. doi: 10.3390/biom14010063.
5
Proteomic analysis of Biliverdin protected cerebral ischemia-reperfusion injury in rats.胆红素蛋白组学分析在大鼠脑缺血再灌注损伤中的保护作用。
Sci Rep. 2023 Nov 22;13(1):20525. doi: 10.1038/s41598-023-47119-3.
6
Bile pigments in emergency and critical care medicine.急诊与重症医学中的胆色素
Eur J Med Res. 2022 Oct 29;27(1):224. doi: 10.1186/s40001-022-00863-0.
7
Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update.胆红素还原酶 A 在代谢和神经退行性疾病中胰岛素信号调节中的作用:最新研究进展。
Int J Mol Sci. 2022 May 16;23(10):5574. doi: 10.3390/ijms23105574.
8
Roles of Heme Oxygenase-1 in Neuroinflammation and Brain Disorders.血红素加氧酶-1在神经炎症和脑部疾病中的作用。
Antioxidants (Basel). 2022 May 8;11(5):923. doi: 10.3390/antiox11050923.
9
Induction of cell apoptosis by biliverdin reductase inhibitor in MCF-7 and MDA-MB-468 breast cancer cell lines: Experimental and in silico studies.胆红素还原酶抑制剂诱导MCF-7和MDA-MB-468乳腺癌细胞系细胞凋亡的实验及计算机模拟研究
EXCLI J. 2021 Oct 21;20:1502-1516. doi: 10.17179/excli2021-4069. eCollection 2021.
10
Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity.类风湿关节炎患者的血浆代谢组学分析鉴定出预测定量疾病活动的生化特征。
Arthritis Res Ther. 2021 Jun 8;23(1):164. doi: 10.1186/s13075-021-02537-4.